NCT01464229 Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability Status COMPLETED Phase PHASE4
NCT01460862 Impact of Omalizumab on Corticosteroid Use, Emergency Room Visits and Hospitalizations Status WITHDRAWN Phase N/A
NCT01460849 Assess Increased Mortality Risk With Each Year of Delayed Tobramycin Solution (TIS) Initiation, and Effect of TIS on Mortality Across Study Centers Status WITHDRAWN Phase N/A
NCT01460836 Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis Status COMPLETED Phase N/A
NCT01459718 Safety and Efficacy of Deferasirox in Combination With Desferoxamine in β-thalassaemia Patients With Severe Cardiac Iron Overload Status TERMINATED Phase PHASE2
NCT01459250 Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects Status COMPLETED Phase PHASE1
NCT01456689 A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT01456676 Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy Status COMPLETED Phase PHASE1
NCT01456663 A Study to Evaluate the Pharmacokinetics of AFQ056 in Subjects With Hepatic Impairment Compared to Healthy Subjects Status COMPLETED Phase PHASE1
NCT01454583 Registry for Ambulant Therapy With RAS-Inhibitors in Hypertension-patients in Germany Status COMPLETED Phase N/A
NCT01452113 Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy Status COMPLETED Phase PHASE2
NCT01451450 Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut Allergy Status WITHDRAWN Phase PHASE2
NCT01449591 Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients Status COMPLETED Phase PHASE2
NCT01447485 Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients Status COMPLETED Phase PHASE1
NCT01443481 Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function Status COMPLETED Phase PHASE1
NCT01442259 An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects Status COMPLETED Phase PHASE1
NCT01442194 Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies Status COMPLETED Phase N/A
NCT01440374 A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia Status COMPLETED Phase PHASE2